🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Subjects completing study DIUR-005 and those who have already completed stu...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-08-18
Trial ID
NCT03062280
Treatments Being Tested
This phase III study is an open-label extension study to be conducted at ap...
Status
Completed
Location
Neurocrine Investigational Site in California
Start Date
2022-04-01
Trial ID
NCT05299554
Treatments Being Tested
This was an open label, randomised, single dose study, comprising Part A (u...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT03051893
Treatments Being Tested
This study is a parallel arm, randomised, open-label study, including dose ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-02-22
Trial ID
NCT02716818
Treatments Being Tested
The purpose of this study is to gather safety and effectiveness information...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2012-12
Trial ID
NCT01735617
Treatments Being Tested
This study will test a new, extended release form of hydrocortisone called ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-08
Trial ID
NCT00519818
Treatments Being Tested
This study is a double-blind, double-dummy, two-way cross-over, randomised,...
Status
Completed
Location
Diurnal Investigational Site in Hamburg
Start Date
2021-11-23
Trial ID
NCT05222152
Treatments Being Tested
This was a single centre, open label, randomised, two period, crossover stu...
Status
Completed
Location
Simbec Research Ltd.
Start Date
2018-02-19
Trial ID
NCT03343327
Treatments Being Tested
This study is a randomized, double-blind, active-controlled, phase III stud...
Status
Completed
Location
Diurnal Investigational Site in Los Angeles
Start Date
2022-05-24
Trial ID
NCT05063994
Treatments Being Tested
This was an open label, randomized, single dose, three period crossover pha...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT03019614
Treatments Being Tested